Cyclophilin A incorporation is not required for human immunodeficiency virus type 1 particle maturation and does not destabilize the mature capsid.

The cellular protein cyclophilin A (CypA) is packaged into human immunodeficiency virus type 1 (HIV-1) virions through a specific interaction with the capsid (CA) domain of the Gag polyprotein. CypA is important for infectivity, but its role in viral replication is currently unknown. Previous reports suggested that CypA promotes uncoating or enhances maturation. We analyzed the morphology and capsid stability of HIV-1 variants defective in CypA binding and of virus grown in the presence of cyclosporin. Both cyclosporin treatment and alteration of Gly89 or Pro90 in the CypA-binding site of CA caused a 5- to 20-fold decrease in CypA incorporation. Virus produced from cyclosporin-treated cells and variants G89V and G89A were 10- to 100-fold less infectious but exhibited normal virion morphologies with regular cone-shaped capsids. Irregular capsid morphologies and lower infectivities were observed for some other variants in the CypA-binding region. Decreased CypA incorporation did not reduce the kinetics of intracellular polyprotein processing or of virus release. No increase in immature particles was observed. These results suggest that CypA does not promote virion maturation. Furthermore, detergent stripping of virus particles with various CypA contents revealed no difference in capsid stability. Based on these results and those reported in the accompanying paper, it appears likely that CypA also is not an uncoating factor. Alternative models for CypA function are discussed.

[1]  H. Kräusslich,et al.  In vitro assembly properties of wild-type and cyclophilin-binding defective human immunodeficiency virus capsid proteins in the presence and absence of cyclophilin A. , 1999, Virology.

[2]  J. Luban,et al.  Human Immunodeficiency Virus Type 1 Replication Is Modulated by Host Cyclophilin A Expression Levels , 1998, Journal of Virology.

[3]  D. Streblow,et al.  Cyclophilin a modulates processing of human immunodeficiency virus type 1 p55Gag: mechanism for antiviral effects of cyclosporin A. , 1998, Virology.

[4]  H. Kräusslich,et al.  Sequential Steps in Human Immunodeficiency Virus Particle Maturation Revealed by Alterations of Individual Gag Polyprotein Cleavage Sites , 1998, Journal of Virology.

[5]  J. Yewdell,et al.  CD4 Glycoprotein Degradation Induced by Human Immunodeficiency Virus Type 1 Vpu Protein Requires the Function of Proteasomes and the Ubiquitin-Conjugating Pathway , 1998, Journal of Virology.

[6]  J. Canon,et al.  Cells with High Cyclophilin A Content Support Replication of Human Immunodeficiency Virus Type 1 Gag Mutants with Decreased Ability To Incorporate Cyclophilin A , 1998, Journal of Virology.

[7]  B. Gowen,et al.  Cryo-electron microscopy reveals ordered domains in the immature HIV-1 particle , 1997, Current Biology.

[8]  H. Göttlinger,et al.  Transfer of the HIV-1 cyclophilin-binding site to simian immunodeficiency virus from Macaca mulatta can confer both cyclosporin sensitivity and cyclosporin dependence. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[9]  W. Sundquist,et al.  Molecular recognition in the HIV-1 capsid/cyclophilin A complex. , 1997, Journal of molecular biology.

[10]  S. Goff,et al.  The morphology of the immature HIV-1 virion. , 1997, Virology.

[11]  W. Sundquist,et al.  Crystal Structure of Human Cyclophilin A Bound to the Amino-Terminal Domain of HIV-1 Capsid , 1996, Cell.

[12]  R. Morimoto,et al.  Molecular Chaperone Machines: Chaperone Activities of the Cyclophilin Cyp-40 and the Steroid Aporeceptor-Associated Protein p23 , 1996, Science.

[13]  H. Göttlinger,et al.  The human immunodeficiency virus type 1 capsid p2 domain confers sensitivity to the cyclophilin-binding drug SDZ NIM 811 , 1996, Journal of virology.

[14]  M. Emerman.  HIV-1, Vpr and the cell cycle , 1996, Current Biology.

[15]  Wesley I. Sundquist,et al.  Structure of the Amino-Terminal Core Domain of the HIV-1 Capsid Protein , 1996, Science.

[16]  J. Luban,et al.  Cyclophilin A is required for an early step in the life cycle of human immunodeficiency virus type 1 before the initiation of reverse transcription , 1996, Journal of virology.

[17]  W. Phares,et al.  Spontaneous mutations in the human immunodeficiency virus type 1 gag gene that affect viral replication in the presence of cyclosporins , 1996, Journal of virology.

[18]  J. Kappes,et al.  The Vif protein of human and simian immunodeficiency viruses is packaged into virions and associates with viral core structures , 1995, Journal of virology.

[19]  F. Bushman,et al.  HIV nuclear import is governed by the phosphotyrosine-mediated binding of matrix to the core domain of integrase , 1995, Cell.

[20]  J. Konvalinka,et al.  An active-site mutation in the human immunodeficiency virus type 1 proteinase (PR) causes reduced PR activity and loss of PR-mediated cytotoxicity without apparent effect on virus maturation and infectivity , 1995, Journal of virology.

[21]  L. Babe,et al.  Defining the Level of Human Immunodeficiency Virus Type 1 ( HIV-1 ) Protease Activity Required for HIV-1 Particle Maturation and Infectivity , 1995 .

[22]  B. Rosenwirth,et al.  Mode of action of SDZ NIM 811, a nonimmunosuppressive cyclosporin A analog with activity against human immunodeficiency virus (HIV) type 1: interference with HIV protein-cyclophilin A interactions , 1995, Journal of virology.

[23]  J. Luban,et al.  Linker insertion mutations in the human immunodeficiency virus type 1 gag gene: effects on virion particle assembly, release, and infectivity , 1995, Journal of virology.

[24]  B. Wolff,et al.  Mode of action of SDZ NIM 811, a nonimmunosuppressive cyclosporin A analog with activity against human immunodeficiency virus type 1 (HIV-1): interference with early and late events in HIV-1 replication , 1995, Journal of virology.

[25]  S. Höglund,et al.  Functional domains of the capsid protein of human immunodeficiency virus type 1 , 1994, Journal of virology.

[26]  J. Sodroski,et al.  Functional association of cyclophilin A with HIV-1 virions , 1994, Nature.

[27]  J. Luban,et al.  Specific incorporation of cyclophilin A into HIV-1 virions , 1994, Nature.

[28]  U. Schubert,et al.  Differential activities of the human immunodeficiency virus type 1-encoded Vpu protein are regulated by phosphorylation and occur in different cellular compartments , 1994, Journal of virology.

[29]  P. Charneau,et al.  Fusion from without directed by human immunodeficiency virus particles , 1994, Journal of virology.

[30]  R. Rudolph,et al.  Prolyl isomerases catalyze antibody folding in vitro , 1993, Protein science : a publication of the Protein Society.

[31]  E. Barklis,et al.  Assembly, processing, and infectivity of human immunodeficiency virus type 1 gag mutants , 1993, Journal of virology.

[32]  Jeremy Luban,et al.  Human immunodeficiency virus type 1 Gag protein binds to cyclophilins A and B , 1993, Cell.

[33]  M. Emerman,et al.  Detection of replication-competent and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated beta-galactosidase gene , 1992, Journal of virology.

[34]  H. Gelderblom.  Assembly and morphology of HIV: potential effect of structure on viral function. , 1991, AIDS.

[35]  R C Craven,et al.  Form, function, and use of retroviral gag proteins. , 1991, AIDS.

[36]  H. Whittle,et al.  Biological and molecular variability of human immunodeficiency virus type 2 isolates from The Gambia , 1990, Journal of virology.

[37]  E. Jacobs,et al.  Assembly and release of HIV-1 precursor Pr55 gag virus-like particles from recombinant baculovirus-infected insect cells , 1989, Cell.

[38]  L J Davis,et al.  Active human immunodeficiency virus protease is required for viral infectivity. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[39]  D. Baltimore,et al.  Standardized and simplified nomenclature for proteins common to all retroviruses , 1988, Journal of virology.

[40]  H. Okayama,et al.  High-efficiency transformation of mammalian cells by plasmid DNA. , 1987, Molecular and cellular biology.

[41]  H. Gendelman,et al.  Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone , 1986, Journal of virology.

[42]  N. Yamamoto,et al.  Infection of HTLV-III/LAV in HTLV-I-carrying cells MT-2 and MT-4 and application in a plaque assay. , 1985, Science.

[43]  K. Sell,et al.  Characterization of a continuous T-cell line susceptible to the cytopathic effects of the acquired immunodeficiency syndrome (AIDS)-associated retrovirus. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[44]  S. Salahuddin,et al.  Restricted expression of human T-cell leukemia--lymphoma virus (HTLV) in transformed human umbilical cord blood lymphocytes. , 1983, Virology.

[45]  D. Baltimore,et al.  High frequency of aberrant expression of moloney murine leukemia virus in clonal infections , 1978, Cell.

[46]  R. Craven,et al.  Dynamic interactions of the Gag polyprotein. , 1996, Current topics in microbiology and immunology.

[47]  K. Mergener,et al.  Analysis of HIV particle formation using transient expression of subviral constructs in mammalian cells. , 1992, Virology.

[48]  L. Jagodzinski,et al.  Complete nucleotide sequences of functional clones of the AIDS virus. , 1987, AIDS research and human retroviruses.

[49]  A. Spurr.  A low-viscosity epoxy resin embedding medium for electron microscopy. , 1969, Journal of ultrastructure research.